enGene

Feb 14, 2024

enGene Announces Leadership Succession Plan

Feb 14, 2024

enGene Announces Oversubscribed $200 Million Private Placement Financing

Jan 29, 2024

enGene Reports Full Year 2023 Financial Results and Recent Operational Progress

Dec 03, 2020

enGene Receives Fast Track Designation for EG-70 for the Treatment of Non-Muscle Invasive Bladder Cancer

Nov 02, 2020

enGene Announces FDA Clearance of IND Application for EG-70, an intravesical dual-immune modulator for the treatment of non-muscle invasive bladder cancer

Oct 29, 2020

enGene Receives Funding Through Cystic Fibrosis Foundation's Path to a Cure for the Discovery of Novel Gene Therapies to Treat Cystic Fibrosis